Pierre M. Gholam
- Epidemiology top 10%
- Hepatology top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Pathology and Forensic Medicine
- Surgery
- Co-authors
- Louis FlancbaumDonald P. KotlerDouglas CharneyJason T. MachanRenuka IyerMatthew S. JohnsonCarol de la MotteBilal Piperdi
- Topics
- Liver Disease Diagnosis and Treatment (12 papers)Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Hepatitis C virus research (4 papers)
- Partner nations
- United States
In The Last Decade
Pierre M. Gholam
19 papers receiving 494 citations
Peers
Comparison fields: 5 of 58
- Epidemiology 376
- Hepatology 200
- Endocrinology, Diabetes and Metabolism 177
- Pathology and Forensic Medicine 104
- Surgery 101
Countries citing papers authored by Pierre M. Gholam
This map shows the geographic impact of Pierre M. Gholam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre M. Gholam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre M. Gholam more than expected).
Fields of papers citing papers by Pierre M. Gholam
This network shows the impact of papers produced by Pierre M. Gholam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre M. Gholam. The network helps show where Pierre M. Gholam may publish in the future.
Co-authorship network of co-authors of Pierre M. Gholam
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre M. Gholam. A scholar is included among the top collaborators of Pierre M. Gholam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre M. Gholam. Pierre M. Gholam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 5 | |
| 4 | Multidisciplinary Management of Patients with Unresectable Hepatocellular Carcinoma: A Critical Appraisal of Current Evidence | 3 |
| 5 | 19 | |
| 6 | 10 | |
| 7 | 40 | |
| 8 | 28 | |
| 9 | 15 | |
| 10 | 0 | |
| 11 | 30 | |
| 12 | The Role of Sorafenib in Hepatocellular Carcinoma. | 6 |
| 13 | 2 | |
| 14 | 0 | |
| 15 | 1 | |
| 16 | 0 | |
| 17 | 2 | |
| 18 | 229 | |
| 19 | Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. | 5 |
| 20 | 94 |
About Pierre M. Gholam
Pierre M. Gholam is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 22 papers that have together received 505 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Hepatology (200 citations), Epidemiology (376 citations) and Endocrinology, Diabetes and Metabolism (177 citations). Pierre M. Gholam has collaborated with scholars based in United States. Frequent co-authors include Louis Flancbaum, Donald P. Kotler, Douglas Charney, Jason T. Machan, Renuka Iyer, Matthew S. Johnson, Carol de la Motte, Bilal Piperdi, Paramananda Saikia and Rebecca L. McCullough. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.